Psychiatric management of anti-NMDAR encephalitis: a cohort analysis.
Nicola WarrenCullen O'GormanGemma McKeonAndrew SwayneStefan BlumDan SiskindPublished in: Psychological medicine (2019)
Psychiatric input is imperative for both acute and longer-term management of anti-NMDAR encephalitis. Primary symptomatic treatment should remain immunotherapy and surgery. Antipsychotic medications have particular value in managing agitation and aggression. Potential side effects from antipsychotic treatment are difficult to differentiate from progression of anti-NMDAR encephalitis but there was no evidence in this cohort of increased antipsychotic sensitivity. Treatment with psychotropic medication should be individualised and adjusted during the course of the illness.